<?xml version='1.0' encoding='utf-8'?>
<document id="8993076"><sentence text="Pharmacokinetic and pharmacodynamic drug interactions with polypharmacotherapy of treatment-resistant affective and obsessive-compulsive disorders." /><sentence text="The concomitant use of multiple therapeutic agents in the treatment of resistant affective and obsessive-compulsive disorders increases the likelihood of a patient experiencing a drug-drug interaction at either the pharmacokinetic or pharmacodynamic level" /><sentence text=" Recent developments in molecular biology and pharmacogenetics have allowed the identification of which psychotropic agents are substrates, inducers, or inhibitors of specific hepatic cytochrome P450 isozymes" /><sentence text=" This increases the predictability of which drug combinations may lead to kinetic interactions" /><sentence text=" However the individual variability in kinetic disposition and pharmacodynamic response still limits the predictability of a drug-drug interaction in an individual patient treated with polytherapy" /><sentence text="" /></document>